5-(2-Fluorophenyl)-1H-pyrrole-3-carboxaldehyde

We are 5-(2-Fluorophenyl)-1H-pyrrole-3-carboxaldehyde CAS:881674-56-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:  5-(2-Fluorophenyl)-1H-pyrrole-3-carboxaldehyde
CAS.NO:   881674-56-2
Synonyms:
5-(2-Fluorophenyl)-1H-pyrrole-3-carbaldehyde
5-(2-Fluorophenyl)-1H-pyrrole-3-carboxaldehyde
1H-Pyrrole-3-carboxaldehyde, 5-(2-fluorophenyl)-

Molecular Formula: C11H8FNO
Molecular Weight:  189.18600

Physical and Chemical Properties:
Density:  1.3±0.1 g/cm3
Boiling point: 370.6±32.0 °C at 760 mmHg
Melting point: /
Flash point: 177.9±25.1 °C
Refractive index:1.616

Specification:
Appearance: white powder
Purity:≥99.0%
Water:0.5% Max.
Sulfated ash:0.1% Max.
Total Impurity:0.5% Max.

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:
Storage:2°C-8°C.Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application: 
Intermediates of Vonoprazan fumarate CAS:1260141-27-2.

Related News: It does not require a production license for the drug substance, and can be produced in an ordinary chemical plant. As long as it reaches a certain level, it can be used for the synthesis of the drug substance.2-Chloro-3-nitro-5-(trifluoromethyl)pyridine CAS:72587-15-6 However, pharmaceutical intermediates are subdivided into primary intermediates and advanced intermediates. Because primary intermediate suppliers can only provide simple intermediate production, they are at the front end of the industrial chain. The pressure of competition and price is the greatest. The price fluctuations of basic chemical raw materials have a greater impact on them.3-bromo-4-clorobenzotrifluoruro CAS:454-78-4 The CTSuccess service uses Catalent’s proprietary StartScoreTM evaluation tool to calculate the complexity of a potential clinical project across more than a dozen specific and objective study characteristics.4300-97-4 The CTSuccess service uses Catalent’s proprietary StartScoreTM evaluation tool to calculate the complexity of a potential clinical project across more than a dozen specific and objective study characteristics.Active pharmaceutical ingredients directly impact disease.